510(k)
53 articles
FDA Patient Preference Information for Medical Devices: 2026 Final Guidance
Guide to FDA Patient Preference Information for medical devices under the 2026 final guidance, including collection methods, validation, regulatory submissions, benefit-risk use, and EU alignment.
eSTAR Additional Information Response Playbook for FDA Deficiency Letters
Playbook for answering FDA Additional Information requests in eSTAR 510(k) and De Novo submissions, covering response tables, file naming, version control, section mapping, and traceability.
FDA AI-Enabled Device Predicate Mining for 510(k) and De Novo
Method for mining FDA AI-enabled device and 510(k) databases to identify predicates, compare technology, avoid weak arguments, and build a defensible predicate matrix.
FDA ASCA Test Report Acceptance Package for 510(k) and De Novo
Step-by-step guide to ASCA evidence packages for 510(k) and De Novo submissions, including summary test reports, declarations, lab accreditation, scope matching, and FDA questions.
FDA Cybersecurity Unresolved Anomalies Table for Premarket Submissions
Guide to building an FDA unresolved software anomalies table for cybersecurity submissions, including CVSS, exploitability, clinical impact, controls, SBOM links, VEX status, and labeling.
FDA Third Party Review Program: 510(k) Due Diligence Checklist
Evaluate whether 3P510k review fits your device, with checks for product code eligibility, Accredited Person conflicts, eSTAR fit, timing, and risk.
Special 510(k) for Software and Cybersecurity Changes: Decision Tree and Evidence Package
Decision tree for when a software or cybersecurity update can use Special 510(k) vs Traditional 510(k) — risk analysis, V&V summary, FDA guidance, and evidence package requirements.
FDA Cybersecurity Premarket Deficiencies: 12 Rejection Reasons
Guide to 12 common FDA cybersecurity premarket deficiencies in 2026, including SBOM, threat modeling, risk assessment, Section 524B, guidance alignment, and practical fixes.
CLIA Waiver for IVDs: Submission Strategy, Study Design, and Dual 510(k) Pathway
Plan a CLIA waiver strategy for IVDs, covering complexity categories, CW content, flex and lay-user studies, Dual 510(k) + CLIA Waiver review, timelines, and deficiencies.
USA Medical Device Registration Cost 2026: U.S. Agent Pricing Guide
Compare U.S. Agent and Official Correspondent pricing models, FDA annual fees and 3-year cash flow scenarios for foreign device manufacturers in 2026.
FDA Emergency Use Authorization for Medical Devices: Regulatory Pathway
FDA EUA guide for medical devices covering Section 564 authority, CBRN emergency triggers, submission criteria, EUA vs 510(k)/PMA, termination, and active EUAs.
FDA Establishment Registration & Device Listing: Complete Compliance Guide
Guide to FDA establishment registration and device listing under 21 CFR Part 807, including FURLS/DRLM, FY 2026 fees, who must register, annual renewal, and common violations.
FDA eSTAR Electronic Submission Template: Complete Guide to 510(k) and De Novo Submissions
Guide to FDA eSTAR electronic submission templates for 510(k) and De Novo, including mandatory use, template structure, completeness checks, submission methods, and common mistakes.
FDA Export Certificates for Medical Devices: CFS, CFG, COE Complete Guide
Guide to FDA export certificates for medical devices, including CFG, CFS, COE, CECATS applications, fees, eligibility, common mistakes, and global market access steps.
Medical Device Registration Cost by Country: 2026 Global Comparison
Compare medical device registration costs, government fees, project budgets, and timelines across the US, EU, Brazil, Japan, Korea, India, China, Saudi Arabia, UK, and more.
Medical Device Startup Regulatory Strategy: From Concept to FDA Clearance (2026)
Build a startup regulatory strategy covering FDA pathway selection, budgets, Q-Subs, eSTAR templates, QMSR readiness, fundraising alignment, and 2026 accelerator programs.
CE + FDA Approval Strategy: Unlock 25+ Markets and Cut Time-to-Market
Learn how dual CE Mark and FDA 510(k)/PMA approval expands access across 25+ markets, speeds reliance registrations, and improves market-entry leverage.
FDA 510(k) Success Rate, Rejection Statistics & Common Reasons (2026)
Data-driven guide to FDA 510(k) clearance rates, RTA holds, NSE decisions, common failure reasons, and practical strategies to improve first-cycle clearance in 2026.
FDA User Fees 2026: MDUFA Fee Schedule and Small Business Planning
Plan FY 2026 medical device user fees with MDUFA V fee amounts, small business reductions, PMA waivers, registration fees, and cost controls.
How to Choose a Medical Device Regulatory Consultant: Complete 2026 Evaluation Guide
Evaluate medical device regulatory consultants with selection criteria, interview questions, red flags, pricing benchmarks, RAC/RAPS signals, and a stage-based decision framework.